Supplementary Tables – Developing an immune signature for triple‑negative breast cancer to predict prognosis and immune checkpoint inhibitor

<b>Supplementary Table S1</b>. Developing an immune signature for triple‑negative breast cancer to predict prognosis and immune checkpoint inhibitor <i>R packages in the study</i> <b>Supplementary Table S2</b>. Developing an immune signature for triple‑negative breast cancer to predict prognosis and immune checkpoint inhibitor <i>66 prognostic IRGs of IPRS</i> <b>Supplementary Table S3</b>. Developing an immune signature for triple‑negative breast cancer to predict prognosis and immune checkpoint inhibitor <i>Multivariate Cox regression for IPRS</i> <b>Supplementary Table S4</b>. Developing an immune signature for triple‑negative breast cancer to predict prognosis and immune checkpoint inhibitor <i>Pathway enrichment analysis for 66 IRGs including KEGG and GO database</i>